Skye Bioscience (SKYE) Operating Leases (2021 - 2025)
Skye Bioscience (SKYE) posted Operating Leases of $83,999 for Q4 2025, down 69.2% from $273,162 a year earlier and down 30.1% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Operating Leases (2021 - 2025) Analysis & Trends
Since Q3 2021, Skye Bioscience has reported Operating Leases for 16 quarters.
- Annual Operating Leases shows a four-year compound annual growth rate of 1.6% (FY2021 to FY2025).
- In prior years, Skye Bioscience's Operating Leases was $273,162 in FY2024 (+59.5%), $171,230 in FY2023 and $78,700 in FY2021.
- The Q4 2025 figure stands as the lowest quarterly Operating Leases since Q3 2022.
- On a year-over-year basis, Operating Leases increased in four of the last seven quarters, with growth averaging 0.2%.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q2 2023, with growth of 543.4%; the weakest was Q3 2022, with a decline of 91.8%.
- According to Business Quant data, Operating Leases for the three prior quarters was $120,207 (Q3 2025), $172,494 (Q2 2025) and $223,466 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 83,999.00 |
| Sep 30, 2025 | 120,207.00 |
| Jun 30, 2025 | 172,494.00 |
| Mar 31, 2025 | 223,466.00 |
| Dec 31, 2024 | 273,162.00 |
| Sep 30, 2024 | 108,062.00 |
| Jun 30, 2024 | 129,907.00 |
| Mar 31, 2024 | 150,953.00 |
| Dec 31, 2023 | 171,230.00 |
| Sep 30, 2023 | 190,510.00 |
| Jun 30, 2023 | 208,588.00 |
| Sep 30, 2022 | 8,227.00 |
| Jun 30, 2022 | 32,422.00 |
| Mar 31, 2022 | 55,906.00 |
| Dec 31, 2021 | 78,700.00 |
| Sep 30, 2021 | 100,583.00 |
API Access
Skye Bioscience Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();